To receive daily emails from Breaking Christian News to your inbox CLICK HERE


SHARE THIS ARTICLE Printer friendly version of this page

HEALTH: Scientists Develop 'Transformative' New Technology to Capture Tumor Cells

News Staff : May 21, 2019  EurekAlert.org

"Physicians can only treat what they can detect. We often can't detect certain subtypes of CTCs, but with the iFCS device we will capture all the subtypes of CTCs and even determine which subtypes are the most informative concerning relapse and disease progression." -Professor Melissa Davis, Weill Cornell Medicine

airlift(Athens, GA)—[University of Georgia] Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers in the University of Georgia College of Engineering followed in developing a new microfluidic device that separates elusive circulating tumor cells (CTCs) from a sample of whole blood. (Screengrab image: iFCS device in action/Credit: UGA)

CTCs break away from cancerous tumors and flow through the bloodstream, potentially leading to new metastatic tumors. The isolation of CTCs from the blood provides a minimally invasive alternative for basic understanding, diagnosis and prognosis of metastatic cancer. But most studies are limited by technical challenges in capturing intact and viable CTCs with minimal contamination.

"A typical sample of 7 to 10 milliliters of blood may contain only a few CTCs," said Leidong Mao, a professor in UGA's School of Electrical and Computer Engineering and the project's principal investigator. "They're hiding in whole blood with millions of white blood cells. It's a challenge to get our hands on enough CTCs so scientists can study them and understand them."

Circulating tumor cells are also difficult to isolate because within a sample of a few hundred CTCs, the individual cells may present many characteristics. Some resemble skin cells while others resemble muscle cells. They can also vary greatly in size.

"People often compare finding CTCs to finding a needle in a haystack," said Mao. "But sometimes the needle isn't even a needle."

To more quickly and efficiently isolate these rare cells for analysis, Mao and his team have created a new microfluidic chip that captures nearly every CTC in a sample of blood—more than 99%—a considerably higher percentage than most existing technologies.

The team calls its novel approach to CTC detection "integrated ferrohydrodynamic cell separation," or iFCS. They outline their findings in a study published in the Royal Society of Chemistry's Lab on a Chip.

The new device could be "transformative" in the treatment of breast cancer, according to Melissa Davis, an assistant professor of cell and developmental biology at Weill Cornell Medicine and a collaborator on the project.

"Physicians can only treat what they can detect," Davis said. "We often can't detect certain subtypes of CTCs, but with the iFCS device we will capture all the subtypes of CTCs and even determine which subtypes are the most informative concerning relapse and disease progression."

Davis believes the device may ultimately allow physicians to gauge a patient's response to specific treatments much earlier than is currently possible.

While most efforts to capture circulating tumor cells focus on identifying and isolating the few CTCs lurking in a blood sample, the iFCS takes a completely different approach by eliminating everything in the sample that's not a circulating tumor cell.

The device, about the size of a USB drive, works by funneling blood through channels smaller in diameter than a human hair. To prepare blood for analysis, the team adds micron-sized magnetic beads to the samples. The white blood cells in the sample attach themselves to these beads. As blood flows through the device, magnets on the top and bottom of the chip draw the white blood cells and their magnetic beads down a specific channel while the circulating tumor cells continue into another channel.

The device combines three steps in one microfluidic chip, another advance over existing technologies that require separate devices for various steps in the process.

"The first step is a filter that removes large debris in the blood," said Yang Liu, a doctoral student in UGA's department of chemistry and the paper's co-lead author. "The second part depletes extra magnetic beads and the majority of the white blood cells. The third part is designed to focus remaining white blood cells to the middle of the channel and to push CTCs to the side walls."

Wujun Zhao is the paper's other lead author. Zhao, a postdoctoral scholar at Lawrence Berkeley National Laboratory, worked on the project while completing his doctorate in chemistry at UGA.

"The success of our integrated device is that it has the capability to enrich almost all CTCs regardless of their size profile or antigen expression," said Zhao. "Our findings have the potential to provide the cancer research community with key information that may be missed by current protein-based or size-based enrichment technologies."

The researchers say their next steps include automating the iFCS and making it more user-friendly for clinical settings. They also need to put the device through its paces in patient trials. Mao and his colleagues hope additional collaborators will join them and lend their expertise to the project. Subscribe for free to Breaking Christian News here







SHARE THIS ARTICLE Printer friendly version of this page

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Other Recent Articles from Breaking Christian News

'I Wouldn't Let Fear Conquer Me': the Flying Wallenda Siblings' Powerful Message 25 Stories above Times Square

"Peace to Prosperity": White House Reveals Mideast Economic Peace Plan

'Synonymous with Opportunity in Short and Long Term': Mexico becomes First Country to Approve USMCA

Christian Scouts Banned from Tour of Pennsylvania National Guard Because of Religious Beliefs

California Pastors Mount Fierce Opposition to Governor Newsome's Abortion Declaration

The Incredible Story of Abraham Lincoln's Journey from Atheist to Devout Christian: How War and Death Changed Him

HEALTH: Turmeric Proven to "Inhibit Bone Cancer Cells While Promoting Growth of Healthy Bone Cells"

This Church Transformed Their County Jail by Bringing Worship to Inmates: "Entire Culture of the Jail Has Shifted"

Jesus Appears to Entire Group of 72 Christians About to be Killed: The Incredible Miracle That Followed is Right Out of the Acts of the Apostles

"It's Real": The Amazing Tattoo Story About Heaven and Life After Death That's Going Viral

Seeing My Baby's Spine on an Ultrasound Was a Game Changer

Court Rules Trump Administration Can Ax Planned Parenthood Funding by as Much as $60 Million

"Not Proportionate": President Trump Orders Military Strike on Iran but Calls It Off at the Last Minute

Burgess Owens on Reparations: 'How About the Democratic Party Pay for All the Misery It Brought to My Race?'

Fearfully and Wonderfully Made: The Group Connecting Imprisoned Moms with Their Girls

Georgia Governor Signs Law Allowing Church, Schools, to Form Their Own Police Forces: A Model for America?

'Stronger Together with Christ': FBI Hosts Multi-Faith Round-table

Abraham Lincoln's Bible Surfaces: "Best Gift God Has Given to Man. But for It, We Would Not Know Right from Wrong"

Canada: Little Girl Traumatized as School Teaches 6-Year-Olds 'There Is No Such Thing as Girls and Boys'

'Answer to My Prayers': Teen Mom Who Chose to Give Her Baby a Family through Adoption Is Now Helping Other Mothers Make This Life-giving Decision



Search the Articles Archives

Keyword:  
Author:  
Words Posted On:  
Day Month Year



To Order by Phone Call: 1-866-354-5245 (1-541-926-3250 outside the U.S.)

BCN Plus

An BCN Paid Advertisement
An BCN Paid Advertisement

An BCN Paid Advertisement
An BCN Paid Advertisement
An BCN Paid Advertisement
BCN Store
Follow BCN on Twitter
Are You Praying for Our Government Leaders?
BCN Staff

Steve Shultz
Steve Shultz, Managing Editor
Founder and Owner


Aimee Herd
Aimee Herd, Editor


Teresa Neumann
Teresa Neumann, Reporter

BCN Plus
Are You Praying for President Trump?
 
 
BCN Contact Info

All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2017. All Rights Reserved.


Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved


Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.

541-924-3906